Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | USP14 | P54578 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL333656 | 0.95 | PPARG (0.43) | PPARGPPARAKDM4EUSP14PLA2G4A | |
| SCHEMBL503870 | 0.93 | MRGPRX4 (0.47) | PPARGPPARAKDM4EPLA2G4AMEN1 | |
| SCHEMBL333611 | 0.92 | PPARG (0.47) | PPARGPPARAKDM4EUSP14MEN1 | |
| SCHEMBL333774 | 0.92 | PPARG (0.46) | PPARGPPARAPLA2G4AMEN1KMT2A | |
| SCHEMBL333845 | 0.91 | PPARG (0.42) | PPARGPPARAKDM4EUSP14THRB | |
| SCHEMBL333665 | 0.89 | MEN1 (0.44) | PPARGPPARAKDM4EUSP14PLA2G4A | |
| SCHEMBL361319 | 0.89 | PPARG (0.42) | PPARGPPARAKDM4EUSP14PLA2G4A | |
| SCHEMBL504356 | 0.89 | PPARG (0.42) | PPARGPPARAKDM4EUSP14PLA2G4A | |
| SCHEMBL503512 | 0.89 | PPARG (0.43) | PPARGPPARAKDM4EUSP14PLA2G4A | |
| SCHEMBL504299 | 0.89 | FFAR1 (0.46) | PPARGPPARALTA4HEPHX2PLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120029016-A1 | Indoles Useful in the Treatment of Inflammation | BIOLIPOX AB (SW) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029016-A1 | Indoles Useful in the Treatment of Inflammation | LTC4S, LTB4R2, LTB4R | PPARG 3260/4885PPARA 1860/4885KDM4E 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.